Robinswood Financial’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Robinswood Financial’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$19.8K	Hold	125	–	–	0.01%	237
2026 Q1	$16K	Hold	125	–	–	0.01%	245
2025 Q4	$15.2K	Hold	125	–	–	﹤0.01%	242
2025 Q3	$12.5K	Sell	125 -130	-51%	-$11.7K	﹤0.01%	243
2025 Q2	$21.1K	Hold	255	–	–	0.01%	212
2025 Q1	$20.7K	Hold	255	–	–	0.01%	198
2024 Q4	$23K	Sell	255 -15	-6%	-$1.45K	0.01%	158
2024 Q3	$26.7K	Hold	270	–	–	0.01%	158
2024 Q2	$25K	Hold	270	–	–	0.01%	164
2024 Q1	$25.3K	Hold	270	–	–	0.01%	127
2023 Q4	$24.1K	Hold	270	–	–	0.01%	121
2023 Q3	$19.7K	Hold	270	–	–	0.01%	131
2023 Q2	$22.5K	Buy	+270	New	+$22.6K	0.01%	109

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Robinswood Financial's XBI Position: Q2 2026 in Review

Robinswood Financial held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q2 2026 at 125 shares worth $19.8K. The position accounts for 0.01% of the portfolio, ranked #237.

Robinswood Financial first reported a position in XBI in Q2 2023 and has held it in 13 quarters since. The position peaked at $26.7K in Q3 2024. 932 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Robinswood Financial held 125 shares of State Street SPDR S&P Biotech ETF worth $19.8K as of Q2 2026.
Robinswood Financial left its State Street SPDR S&P Biotech ETF share count unchanged in Q2 2026.
State Street SPDR S&P Biotech ETF made up 0.01% of Robinswood Financial's portfolio in Q2 2026, its #237 holding.
Robinswood Financial first reported a position in State Street SPDR S&P Biotech ETF in Q2 2023 and has held it in 13 quarters since.
Robinswood Financial's State Street SPDR S&P Biotech ETF position peaked at $26.7K in Q3 2024.
932 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Robinswood Financial's 13F filing for Q2 2026, filed 15 Jul 2026.